In colon cancer, interleukin-6 (IL-6) is a tumor-promoting factor by inducing neoplastic cell proliferation through activation of the STAT3 oncogene in dysplastic epithelial cells, and its levels correlates with tumor size. Here, IL6 is linked to neoplasm.